RNS Number : 2602H
Omega Diagnostics Group PLC
02 December 2020
02 December 2020
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Director / PDMR Dealings
Omega Diagnostics (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces that on 1 December 2020 Colin King, Chief Executive Officer, bought 35,721 Ordinary Shares of 4 pence each in the Company, at a price of 53.19 pence per share.
Following completion, Mr King is interested in 853,973 Ordinary Shares, representing 0.47 per cent. of the issued share capital of the Company.
The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation is appended below.
The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.
Contacts:
|
Omega Diagnostics Group PLC
|
Tel: 01259 763 030
|
|
Colin King, Chief Executive
|
www.omegadiagnostics.com
|
|
Kieron Harbinson, Group Finance Director
|
|
|
|
|
|
|
|
|
finnCap Ltd
|
Tel: 020 7220 0500
|
|
Geoff Nash/Teddy Whiley (Corporate Finance)
|
|
|
Alice Lane (ECM)
|
|
|
|
|
|
Walbrook PR Limited
|
Tel: 020 7933 8780 or
omega@walbrookpr.com
|
|
Paul McManus
|
Mob: 07980 541 893
|
|
Lianne Cawthorne
|
Mob: 07584 391 303
|
|
Details of the person discharging managerial responsibilities/person closely associated
|
|
a)
|
Name:
|
Colin King
|
|
Reason for the notification
|
|
a)
|
Position/status:
|
Chief Executive Officer
|
|
b)
|
Initial notification/Amendment:
|
Initial Notification
|
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name:
|
Omega Diagnostics Group Plc
|
|
b)
|
LEI:
|
2138007U9P4BTZTYIR92
|
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument:
Identification code:
|
Ordinary Shares of 4 pence each
GB00B1VCP282
|
|
b)
|
Nature of the transaction:
|
Purchase of Ordinary Shares
|
|
c)
|
Price(s) and volume(s):
|
|
Price(s)
|
Volume(s)
|
|
£0.5319
|
35,721
|
|
|
d)
|
Aggregated information:
·
Aggregated volume:
·
Price:
|
Single transaction as in 4 c) above
|
Price(s)
|
Volume(s)
|
|
£0.5319
|
35,721
|
|
|
e)
|
Date of the transaction:
|
1 December 2020
|
|
f)
|
Place of the transaction:
|
LSE
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
DSHGIBDDSSGDGGD
|
